These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3608533)
21. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642. Hock CE; Lefer DJ; Lefer AM Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301 [TBL] [Abstract][Full Text] [Related]
22. Protective actions of aprotinin in acute traumatic shock. Araki H; Lefer AM Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):316-23. PubMed ID: 316692 [TBL] [Abstract][Full Text] [Related]
23. Protective effects of a novel 21-aminosteroid during splanchnic artery occlusion shock. Johnson G; Lefer AM Circ Shock; 1990 Feb; 30(2):155-64. PubMed ID: 2311204 [TBL] [Abstract][Full Text] [Related]
24. Protective actions of nafazatrom in traumatic shock. Lefer AM; Messenger M Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831 [TBL] [Abstract][Full Text] [Related]
25. Role of the splanchnic visceral organs in development of tolerance to traumatic shock. Araki H; Sollott SJ; Lefer AM J Trauma; 1980 Dec; 20(12):1046-51. PubMed ID: 7452749 [TBL] [Abstract][Full Text] [Related]
26. Beneficial actions of CP-0127, a novel bradykinin receptor antagonist, in murine traumatic shock. Christopher TA; Ma XL; Gauthier TW; Lefer AM Am J Physiol; 1994 Mar; 266(3 Pt 2):H867-73. PubMed ID: 8160833 [TBL] [Abstract][Full Text] [Related]
27. Anti-shock effects of human superoxide dismutase in splanchnic artery occlusion (SAO) shock. Bitterman H; Aoki N; Lefer AM Proc Soc Exp Biol Med; 1988 Jul; 188(3):265-71. PubMed ID: 3393543 [TBL] [Abstract][Full Text] [Related]
28. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock. Bitterman H; Smith BA; Lefer AM Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353 [TBL] [Abstract][Full Text] [Related]
29. Sialyl Lewisx-containing oligosaccharide exerts beneficial effects in murine traumatic shock. Skurk C; Buerke M; Guo JP; Paulson J; Lefer AM Am J Physiol; 1994 Dec; 267(6 Pt 2):H2124-31. PubMed ID: 7528988 [TBL] [Abstract][Full Text] [Related]
30. Beneficial effect of anisodamine in hemorrhagic shock. Su J; Hock CE; Lefer AM Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045 [TBL] [Abstract][Full Text] [Related]
31. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock. Bitterman H; Phillips GR; Dragon G; Lefer AM J Pharmacol Exp Ther; 1987 Jul; 242(1):8-14. PubMed ID: 3039116 [TBL] [Abstract][Full Text] [Related]
32. Protective effects of a novel thromboxane analog in lethal traumatic shock. Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102 [TBL] [Abstract][Full Text] [Related]
33. Beneficial effects of oligotide, a novel oligodeoxyribonucleotide, in murine traumatic shock. Skurk C; Nuss C; Lefer AM Shock; 1995 Jan; 3(1):13-20. PubMed ID: 7531603 [TBL] [Abstract][Full Text] [Related]
34. Salutary effects of two verapamil analogs in traumatic shock. Hock CE; Daitch JS; Lefer AM Pharm Res; 1985 May; 2(3):130-4. PubMed ID: 24272690 [TBL] [Abstract][Full Text] [Related]
35. Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shock. Bitterman H; Lefer AM Prostaglandins Leukot Essent Fatty Acids; 1988 May; 32(2):63-70. PubMed ID: 3406041 [TBL] [Abstract][Full Text] [Related]
36. Administration of polymerized bovine hemoglobin improves survival in a rat model of traumatic shock. Hayward R; Lefer AM Methods Find Exp Clin Pharmacol; 1999; 21(6):427-33. PubMed ID: 10445236 [TBL] [Abstract][Full Text] [Related]